How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

75,669 results for

Cancer Prevention

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: The importance of cancer prevention in addition to cancer detection (PubMed)

Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: The importance of cancer prevention in addition to cancer detection Colorectal cancer (CRC) screening can be undertaken utilizing a variety of distinct approaches, which provides both opportunities and confusion. Traditionally, there has often been a trade-off between the degree of invasiveness of a screening test and its ability to prevent cancer, with fecal occult blood testing (FOBT) and optical

Full Text available with Trip Pro

2016 Abdominal radiology (New York)

42. Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model. (PubMed)

Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model. Survival but not cure rates have improved for epithelial ovarian cancer (EOC), demonstrating the need for effective prevention. Targeted prevention in BRCA carriers by risk reducing surgery (RRS) prevents 80% of cases but incurs additional up-front costs, compensated for by the potential for long term (...) savings from treatment avoidance. Does prevention represent value for money? In the absence of long-term data from prospective trials, determining the cost effectiveness of a prevention strategy requires economic modelling.A patient level simulation was developed comparing outcomes between two groups, using Canadian data. Group 1: no mutation testing with treatment if EOC developed. Group 2: cascade testing (index patient BRCA tested and the first and second-degree relatives tested if index patient

2019 Gynecologic Oncology

43. Therapeutic cancer prevention: achievements and ongoing challenges. A focus on breast and colorectal cancer. (PubMed)

Therapeutic cancer prevention: achievements and ongoing challenges. A focus on breast and colorectal cancer. The constant increase of cancer incidence and the huge costs of new treatments make cancer prevention a crucial goal in order to maintain sustainable public health systems across the world. Carcinogenesis is a multistep process, which allows time for active intervention with natural or synthetic agents to stop or reverse the pathological process. Cancer prevention medicine can (...) value to detect and monitor the efficacy of interventions in clinical trials and beyond. In the field of cancer prevention medicine, breast and colon cancer demonstrates the strongest clinical evidence that pharmacological intervention can lower cancer risk. Here, we offer an overview of the major clinical achievements for these cancers and the critical issues to improve implementation and clinical uptake of efficacious therapies, as well as further developments needed in the field of preventive

Full Text available with Trip Pro

2019 Molecular oncology

44. Circadian genes and risk of prostate cancer in the prostate cancer prevention trial. (PubMed)

Circadian genes and risk of prostate cancer in the prostate cancer prevention trial. Circadian genes have been considered as a possible biological mechanism for the observed relationship between circadian rhythm disruptions and increased risk of hormone-related cancers. In the current study, we investigated the relationship between circadian gene variants and prostate cancer risk and whether reducing bioavailable testosterone modifies the circadian genes-prostate cancer relationship. We (...) conducted a nested case-control study among Caucasian men in the Prostate Cancer Prevention Trial (PCPT), a randomized placebo-controlled clinical trial to assess if finasteride (an androgen bioactivation inhibitor) could prevent prostate cancer. We evaluated the associations between 240 circadian gene variations and prostate cancer risk among 1092 biopsy-confirmed prostate cancer cases and 1089 biopsy-negative controls in the study (642 cases and 667 controls from the placebo group; 450 cases and 422

2019 Molecular carcinogenesis

45. Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign. (PubMed)

Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign. Sunbed use has been significantly associated with increased risk of melanoma and non-melanoma skin cancer (NMSC), but its relationship with melanoma's risk factors such as high nevus count, atypical nevi and lentigines is poorly studied. Euromelanoma is a skin cancer prevention campaign conducted all over Europe. It offers a once-a-year screening during (...) which participants' data, including sunbed use and phenotype, are collected via questionnaires.To investigate the association of sunbed use with nevus count, atypical nevi, lentigines and suspicion of skin cancer.To ensure reliability of the data, we defined inclusion and exclusion criteria for countries' eligibility for the risk analysis. Multivariate logistic regression models (including age, gender, education, skin type, family history of melanoma, personal history of skin cancer, any sun

Full Text available with Trip Pro

2019 Journal of the European Academy of Dermatology and Venereology

46. Cancer league actions against sunbed use for skin cancer prevention. (PubMed)

Cancer league actions against sunbed use for skin cancer prevention. The incidence of non-melanoma and melanoma skin cancer has been rising in Europe. Although the World Health Organization's International Agency for Research on Cancer has since 2009 classified sunbeds as a Group 1 carcinogen, sunbed use, especially by those under the age of 18, continues to be a concern. As the only platform for cancer leagues in Europe, the Association of European Cancer Leagues decided to explore interest

2019 Journal of the European Academy of Dermatology and Venereology

47. Standardizing Measurement of Social and Behavioral Dimensions of Cancer Prevention and Control to Enhance Outreach and Engagement in NCI-Designated Cancer Centers. (PubMed)

Standardizing Measurement of Social and Behavioral Dimensions of Cancer Prevention and Control to Enhance Outreach and Engagement in NCI-Designated Cancer Centers. 30670459 2019 03 08 1538-7755 28 3 2019 Mar Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Cancer Epidemiol. Biomarkers Prev. Standardizing Measurement of Social and Behavioral Dimensions of Cancer Prevention (...) and Control to Enhance Outreach and Engagement in NCI-Designated Cancer Centers. 431-434 10.1158/1055-9965.EPI-18-0794 Gage-Bouchard Elizabeth A EA Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York. Elizabeth.bouchard@roswellpark.org. Rawl Susan M SM https://orcid.org/0000-0003-2052-2853 Simon Cancer Center, Indiana University, Indianapolis, Indiana. eng P30 CA016056 CA NCI NIH HHS United States P30 CA082709 CA NCI NIH HHS United States Editorial 2019

2019 Cancer Epidemiology & Biomarkers and Prevention

48. Common osteoporosis drugs may prevent breast cancer spreading to bone

Common osteoporosis drugs may prevent breast cancer spreading to bone Common osteoporosis drugs may prevent breast cancer spreading to bone Discover Portal Discover Portal Common osteoporosis drugs may prevent breast cancer spreading to bone Published on 13 March 2018 doi: Drugs commonly prescribed to prevent bone thinning probably help prevent the spread of early breast cancer to the bones in a few women, when taken in addition to standard cancer therapies. However, the overall benefits may (...) be small, for example preventing spread to bone or death in about one extra woman in every 100 treated for about five years. This is a complex area because many of the treatments for breast cancer are known to worsen bone thinning, but there are other bone strengthening benefits to these drugs. This large review of 44 studies with more than 37,000 participants looked at women with either early breast cancer or advanced breast cancer with or without bone involvement. The reviewers also concluded

2018 NIHR Dissemination Centre

49. Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes

Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes PreventionandscreeninginBRCAmutationcarriersand otherbreast/ovarianhereditarycancersyndromes: ESMOClinicalPracticeGuidelinesforcancerprevention andscreening † S.Paluch-Shimon 1 ,F.Cardoso 2 ,C.Sessa 3 ,J.Balmana 4 ,M.J.Cardoso 2 ,F.Gilbert 5 &E.Senkus 6 , onbehalfoftheESMOGuidelinesCommittee * 1 DivisionofOncologyandtheDrPinchasBorensteinTalpiotMedicalLeadershipProgram,ShebaMedicalCenter (...) ,RamatGan,Israel; 2 BreastUnit,ChampalimaudClinical Center,Lisbon,Portugal; 3 OncologyInstituteofSouthernSwitzerland,OspedaleSanGiovanni,Bellinzona,Switzerland; 4 Valld`HebronUniversityHospitalInstitut d’Oncologia,Barcelona,Spain; 5 SchoolofClinicalMedicine,UniversityofCambridge,Cambridge,UK; 6 DepartmentofOncologyandRadiotherapy,MedicalUniversityof Gdan ´sk,Gdan ´sk,Poland The guidelines will focus on cancer prevention and screening among individuals known to harbour a pathogenic BRCA1/2 mutation

2017 European Society for Medical Oncology

50. Colorectal Cancer Prevention: Lifestyle

Colorectal Cancer Prevention: Lifestyle Colorectal cancer prevention: lifestyle | ACPGBI Toggle navigation Toggle site search Search the ACPGBI website Submit Case reports, procedural guidelines, good practice, conference presentations, videos, e-publications and more, searchable by specialism and audience. Upcoming and future colorectal conferences, courses, workshops and meetings, searchable by location, specialism and audience. Keep up-to-date on campaigns, publications, research (...) and training, plus announcements and annual meeting news. > > > Colorectal cancer prevention: lifestyle Colorectal cancer prevention: lifestyle Annie Anderson's presentation at the 2016 ACPGBI Annual Meeting This guide is designed to support clinical teams, commissioners, employers and managers to understand and evaluate the contribution of CNSs in cancer as they plan their local workforce and service improvement strategies Tagged with: Please enable JavaScript to view the Registered office: Royal College

2017 Association of Coloproctology of Great Britain and Ireland

51. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting (...) in advanced cancer patients | Annals of Oncology | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation September 2016 Article Contents Article Navigation 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients F. Roila 1Medical Oncology, Santa Maria

Full Text available with Trip Pro

2016 International Society for Oral Oncology

52. Oral cryotherapy: preventing mouth soreness and ulcers in people having cancer treatments

Oral cryotherapy: preventing mouth soreness and ulcers in people having cancer treatments Oral cryotherapy: preventing mouth soreness and ulcers in people having cancer treatments - Evidently Cochrane Search and hit Go By January 15, 2016 // Oral mucositis is a common side effect of high-dose chemotherapy: can cryotherapy help? It’s a long time since I worked on a children’s cancer ward, but I do remember that sore mouths were a miserable problem for many and that we did several things to help (...) prevent ulceration, including giving the children ice chips to suck. So I was interested to see a brand new Cochrane review investigating whether making the mouth cold (with ice, iced water, ice cream or ice lollies) is effective in preventing ulceration in people having cancer treatments. Properly termed oral cryotherapy, it’s free, it’s simple, it’s natural, but does it work? It would be good to know. It’s not just a sore mouth Oral mucositis is a common side effect of high-dose chemotherapy

2016 Evidently Cochrane

53. Cervical Cancer Screening and Prevention

Cervical Cancer Screening and Prevention Sign In (ACOG) Sign in to your ACOG account Email is required. Please enter valid Email. was not found in our system. Would you like to associated with your account? Forgot your email address? JSOG Member? © 2019 - American College of Obstetricians and Gynecologists

2016 American College of Obstetricians and Gynecologists

54. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline | Journal of Clinical Oncology Search in: Menu Article Tools ASCO SPECIAL ARTICLE Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2016.70.5400 Journal of Clinical Oncology - published online before print December 5 (...) , 2016 PMID: Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline x Saro H. Armenian , x Christina Lacchetti , x Ana Barac , x Joseph Carver , x Louis S. Constine , x Neelima Denduluri , x Susan Dent , x Pamela S. Douglas , x Jean-Bernard Durand , x Michael Ewer , x Carol Fabian , x Melissa Hudson , x Mariell Jessup , x Lee W. Jones , x Bonnie Ky , x Erica L. Mayer , x Javid Moslehi , x Kevin Oeffinger , x

2016 American Society of Clinical Oncology Guidelines

55. Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication

Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication Final Update Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 11/16/2018 6:27:19 PM You are here: Final Summary Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication Release Date: February 2014 Recommendation Summary Summary of Recommendations and Evidence (...) Population Recommendation Grade Use of Multivitamins to Prevent Cardiovascular Disease or Cancer The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamins for the prevention of cardiovascular disease or cancer. Single- or Paired-Nutrient Supplements for Prevention of Cardiovascular Disease or Cancer The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single

2014 U.S. Preventive Services Task Force

56. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force

Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the US Preventive Services Task Force Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the US (...) Preventive Services Task Force Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP CRD summary This review concluded that evidence for an effect of nutritional doses on cardiovascular disease, cancer, or mortality in healthy individuals without nutritional deficiencies was limited. In most cases there were insufficient data to draw any conclusion but for vitamin E and beta-carotene a lack of benefit was consistent across several trials. This conclusion is likely to be reliable. Authors' objectives

Full Text available with Trip Pro

2013 DARE.

57. The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines (PubMed)

The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines 30084718 2019 03 04 2378-9506 4 2018 Jul Journal of global oncology J Glob Oncol The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines. 1-3 10.1200/JGO.18.00096 Garcia-Gonzalez Pat P Pat Garcia-Gonzalez and Erin Schwartz, The Max (...) Foundation, Seattle, WA; Gilberto Lopes, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA. Lopes Gilberto G Pat Garcia-Gonzalez and Erin Schwartz, The Max Foundation, Seattle, WA; Gilberto Lopes, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA. Schwartz Erin E Pat Garcia-Gonzalez and Erin Schwartz, The Max Foundation

Full Text available with Trip Pro

2018 Journal of global oncology

58. Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention (PubMed)

Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention Patients with bladder cancer are at high risk of developing both venous and arterial thromboembolic events. Factors that contribute to this phenomenon include the hypercoagulable state induced by the malignancy itself, medical comorbidities that are common in this predominantly elderly patient population as well as treatments such as prolonged pelvic surgery and cisplatin-based chemotherapy. While formal (...) guidelines address prevention of venous thromboembolism in patients undergoing radical cystectomy, consensus regarding the role of pharmacologic prophylaxis in patients with bladder cancer being treated with chemotherapy, either with neoadjuvant or adjuvant intent in conjunction with radical cystectomy, as part of bladder preservation protocols or for metastatic disease, has proved elusive. The present narrative review was undertaken to define the incidence of and identify risk factors

Full Text available with Trip Pro

2018 Bladder cancer (Amsterdam, Netherlands)

59. Breast Cancer Prevention: Current Approaches and Future Directions (PubMed)

Breast Cancer Prevention: Current Approaches and Future Directions The topic of breast cancer prevention is very broad. All aspects of the topic, therefore, cannot be adequately covered in a single review. The objective of this review is to discuss strategies in current use to prevent breast cancer, as well as potential approaches that could be used in the future. This review does not discuss early detection strategies for breast cancer, including breast cancer screening. The breast is the most (...) common site among women worldwide of noncutaneous cancer. Many clinical and genetic factors have been found to increase a woman's risk of developing the disease. Current strategies to decrease a woman's risk of developing breast cancer include primary prevention, such as avoiding tobacco, exogenous hormone use and excess exposure to ionizing radiation, maintaining a normal weight, exercise, breastfeeding, eating a healthy diet and minimizing alcohol intake. Chemoprevention medications are available

Full Text available with Trip Pro

2018 European journal of breast health

60. Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? (PubMed)

Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? Purpose There remains considerable international variation in breast cancer incidence and mortality, but a comprehensive examination of rates by country level economic, development and cancer prevention policies is lacking. Materials and Methods We compared GLOBOCAN 2012 age-specific breast cancer incidence and mortality rates for 177 countries by using (...) ; economic development indicators additionally increased this percentage by approximately 4%. Country-level cancer prevention policy indicators contributed little to explanation of the overall variation in incidence and mortality after analysis accounted for age and country-level income; however, an overall resource summary index of greater economic development and cancer prevention policies was related to lower mortality within each major income level. Conclusion Although breast cancer incidence

Full Text available with Trip Pro

2018 Journal of global oncology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>